Nicholas A. Vitanza

Ben Towne Center for Childhood Cancer Research

Seattle Children’s Research Institute

BIOGRAPHY

Nicholas A. Vitanza has not added Biography.

If you are Nicholas A. Vitanza and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Immunotherapy for brain tumors: understanding early successes and limitations.

Expert review of neurotherapeutics Mar, 2018 | Pubmed ID: 29322843

Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.

Neuro-oncology Jan, 2019 | Pubmed ID: 30169876

Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials.

Current treatment options in neurology Jul, 2019 | Pubmed ID: 31290035

EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma.

Oncotarget Dec, 2019 | Pubmed ID: 31903167

Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.

Journal of neuro-oncology Jul, 2020 | Pubmed ID: 32556862

Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.

Neuro-oncology Mar, 2021 | Pubmed ID: 33130903

Considerations when treating high-grade pediatric glioma patients with immunotherapy.

Expert review of neurotherapeutics Feb, 2021 | Pubmed ID: 33225764

MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study.

Neuro-oncology advances , 2021 | Pubmed ID: 33977272

Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis.

Nature medicine Sep, 2021 | Pubmed ID: 34253928

Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.

Oncogene Jan, 2022 | Pubmed ID: 34759345

Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma.

Neuro-oncology advances , 2021 | Pubmed ID: 34988452

Two cases of pineal anlage tumor with molecular analysis.

Pediatric blood & cancer Apr, 2022 | Pubmed ID: 35129878

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.

Neuro-oncology Aug, 2022 | Pubmed ID: 35137228

Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas.

Neuro-oncology Sep, 2022 | Pubmed ID: 35157764

The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies.

Neuro-oncology Sep, 2022 | Pubmed ID: 35481923

Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.

Cancer discovery Jan, 2023 | Pubmed ID: 36259971

Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.

Neuro-oncology advances , 2022 | Pubmed ID: 36382108

Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety.

Neoplasia (New York, N.Y.) Feb, 2023 | Pubmed ID: 36599192

Functional genomic analysis of adult and pediatric brain tumor isolates.

bioRxiv : the preprint server for biology Jan, 2023 | Pubmed ID: 36711964

INSTITUTIONS

Seattle Children’s Research Institute

University of Washington

JOVE ARTICLES

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice

Kyra Harvey¹,

Peter J. Madsen^2,3,

Tiffany Smith²,

Crystal Griffin^1,2,

Luke Patterson^1,2,

Nicholas A. Vitanza^4,5,

Phillip B. Storm^2,3,

Adam C. Resnick^2,3,

Jessica B. Foster^1,2

¹Division of Oncology, Children’s Hospital of Philadelphia,

²Center for Data Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia,

³Division of Neurosurgery, Children’s Hospital of Philadelphia,

⁴Ben Towne Center for Childhood Cancer Research, Seattle Children’s Research Institute,

⁵Department of Pediatrics, Seattle Children’s Hospital, University of Washington

Cancer Research

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

Nicholas A. Vitanza

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Ben Towne Center for Childhood Cancer Research

Seattle Children’s Research Institute

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice

Ben Towne Center for Childhood Cancer Research